Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.

ClinicalTrials.gov ID: NCT00755287

Public ClinicalTrials.gov record NCT00755287. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 6:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Open-label, Active-controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin-naïve Type 2 Diabetic Patients Inadequately Controlled With Metformin and Sulphonylurea Combination Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This 3-arm study will assess the efficacy, safety and tolerability of taspoglutide compared to insulin glargine in patients with insulin-naive type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea combination therapy. Patients will be randomized to receive taspoglutide (10 mg once weekly, or 10mg once weekly for 4 weeks followed by 20mg once weekly) or insulin glargine (starting dose 10 IU/day) in a ratio of 1:1:1 in addition to continued prestudy metformin treatment. The anticipated time on study treatment is 2+ years, and the target sample size if 500+ individuals.

Study identification

NCT ID
NCT00755287
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
1,072 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2008 (Type not available)
Primary completion
Dec 2010 (Actual)
Completion
Dec 2010 (Actual)
Last update posted
Jul 29, 2016

2008 – 2010

United States locations

U.S. sites
74
U.S. states
30
U.S. cities
66
Facility City State ZIP Site status
Not listed Phoenix Arizona 85032 —
Not listed Searcy Arkansas 72143 —
Not listed Concord California 94520 —
Not listed Huntington Beach California 92648 —
Not listed Los Angeles California 90015 —
Not listed Los Angeles California 90025 —
Not listed Los Gatos California 95032 —
Not listed Roseville California 95661 —
Not listed San Diego California 92109 —
Not listed Santa Ana California 92705 —
Not listed Westlake Village California 91361 —
Not listed Washington D.C. District of Columbia 20010 —
Not listed Green Cove Springs Florida 32043 —
Not listed Hialeah Florida 33013 —
Not listed Jacksonville Florida 32204 —
Not listed Jacksonville Florida 32216 —
Not listed Ormond Beach Florida 32174 —
Not listed Oviedo Florida 32765 —
Not listed Palm Harbor Florida 34684 —
Not listed Trinity Florida 34655 —
Not listed Zephyrhills Florida 33542 —
Not listed Atlanta Georgia 30338 —
Not listed Quincy Illinois 62301 —
Not listed Springfield Illinois 62704-1433 —
Not listed Avon Indiana 46123 —
Not listed Indianapolis Indiana 46260 —
Not listed Arkansas City Kansas 67005 —
Not listed Crestview Hills Kentucky 41017 —
Not listed Metairie Louisiana 70006 —
Not listed Sunset Louisiana 70584 —
Not listed Portland Maine 04101 —
Not listed North East Maryland 21901 —
Not listed Worchester Massachusetts 01605 —
Not listed Saint Claire Shores Michigan 48081 —
Not listed Jackson Mississippi 39216 —
Not listed Picayune Mississippi 39466 —
Not listed Springfield Missouri 65807 —
Not listed Grand Island Nebraska 68803 —
Not listed Omaha Nebraska 68105 —
Not listed Omaha Nebraska 68131 —
Not listed Henderson Nevada 89014 —
Not listed Blackwood New Jersey 08012 —
Not listed Cherry Hill New Jersey 08002 —
Not listed Moorestown New Jersey 08057 —
Not listed Toms River New Jersey 08753 —
Not listed Toms River New Jersey 08755 —
Not listed Albany New York 12206-1098 —
Not listed Flushing New York 11365 —
Not listed Mineola New York 11501 —
Not listed Asheville North Carolina 28803 —
Not listed Harrisburg North Carolina 28075 —
Not listed Fargo North Dakota 58103 —
Not listed Centerville Ohio 45459 —
Not listed Cincinnati Ohio 45242 —
Not listed Genoa Ohio 43430-1143 —
Not listed Toledo Ohio 43606 —
Not listed Altoona Pennsylvania 16602 —
Not listed Bensalem Pennsylvania 19020 —
Not listed Feasterville Pennsylvania 19053 —
Not listed Harrisburg Pennsylvania 17112 —
Not listed Jefferson Hills Pennsylvania 15025 —
Not listed Philadelphia Pennsylvania 19107 —
Not listed Philadelphia Pennsylvania 19146 —
Not listed Scranton Pennsylvania 18510 —
Not listed Tipton Pennsylvania 16684 —
Not listed Orangeburg South Carolina 29115 —
Not listed Johnson City Tennessee 37604 —
Not listed Dallas Texas 75230 —
Not listed Dallas Texas 75246 —
Not listed Dallas Texas 75390 —
Not listed Houston Texas 77024 —
Not listed Houston Texas 77030 —
Not listed Richmond Virginia 23249 —
Not listed Waukesha Wisconsin 53189 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 136 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00755287, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 29, 2016 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00755287 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →